Is Novavax Stock A Sell After An Unexpected Side Effect Torpedoed Its Testing Plans?

Is Novavax Stock A Sell After An Unexpected Side Effect Torpedoed Its Testing Plans? · Investor's Business Daily
ALLISON GATLIN
4 min read

In This Article:

Novavax stock took a hit in mid-October after the FDA placed its request to begin testing two new products on hold. Is NVAX stock a sell?

Recommended Stories